GINZA NOA CLINIC
Tokyo, Japan International Patient Support
Contact Us

What Happens at a Stem Cell Consultation?

At a stem cell consultation, a doctor reviews your diagnosis, symptoms, medical records, and previous treatment, then discusses whether a particular treatment is appropriate. An in-person visit may include an examination. You should hear about the evidence, risks, alternatives, costs, and any checks still needed. The outcome may be further assessment, a treatment proposal to consider, or advice not to proceed.

This is general information, not personal medical advice. A consultation is an assessment; do not assume that booking one also books cell collection or an injection.

What Happens at a Stem Cell Consultation?

What to Bring

Ask the clinic which records the doctor needs before the appointment. Start with your diagnosis, relevant scan reports and original images, specialist letters, and previous procedure notes. Include a current list of medicines, supplements, and allergies. If your diagnosis is uncertain, say so rather than trying to fit your symptoms into a treatment offer.

Write a short timeline of your symptoms and treatments. Note what helped, what did not, and what you want to be able to do. A specific goal, such as walking to the shops with fewer stops, gives the doctor something clearer to discuss than “feeling younger.”

If you are arranging care in Japan, check where the consultation falls within the process from record review to follow-up. Ask whether the appointment is with a treating doctor or a patient-support coordinator, whether interpretation is available, how long to allow, and how to send records securely. Do not arrange extra tests on your own just to complete a checklist; ask which tests are needed and why.

What the Doctor Does

Reviews Your History and Goals

The discussion should connect your symptoms to a diagnosis, not start with a package price. Explain when the problem began, whether it is changing, and how it affects sleep, work, movement, or daily tasks. For joint pain, describe where it hurts and what brings it on. For another condition, bring the relevant specialist’s assessment.

Go through previous treatment and how long any benefit lasted. Tell the doctor about infections, cancer history, heart or lung disease, bleeding problems, pregnancy, and previous regenerative procedures. These are matters for an individual safety review, not a universal list of automatic exclusions. Do not stop prescribed medicine unless the prescribing clinician advises it.

Examines You When Needed

An in-person assessment may include vital signs and an examination relevant to the problem. For a knee complaint, that might mean looking at swelling, movement, and walking. Ask what the findings change about the diagnosis or proposed treatment.

A video appointment can cover history and records, but it cannot provide the same hands-on examination. Ask what remains provisional and whether an in-person examination or further tests are needed before a treatment decision.

Explains Whether You Are a Candidate

The answer should include reasons. A doctor may need a clearer diagnosis, a specialist opinion, or updated tests. They may advise standard treatment instead, or explain that the evidence does not justify the proposed intervention.

For a blood-forming stem cell transplant in cancer care, eligibility depends on factors such as cancer type and stage, previous treatment, other health problems, ability to tolerate conditioning treatment, and whether suitable cells are available. This is a different assessment from a private clinic’s proposed cell injection Stem cell transplant.

Possible outcome What to clarify before leaving
Further assessment Which record, test, or specialist review is missing, who arranges it, and when the doctor will reconsider.
A proposal to consider What is being offered, what remains uncertain, and whether any safety checks are still outstanding.
Advice not to proceed Why the treatment is unsuitable or unsupported, and which other care or referral to discuss with your usual doctor.

Identifies the Exact Treatment

Ask for the product or cell preparation’s name, cell source, dose, processing method, route of administration, and proposed schedule. Your own cells and donor cells are not interchangeable descriptions. Neither are an injection into a joint and an infusion into a vein. These details also matter when comparing stem cell hospitals in Japan.

Separate established transplant care, an approved product for a specific indication, and an experimental intervention. Blood-forming stem cell transplants can restore blood-cell production after high-dose cancer treatment; this does not establish that a different cell preparation will repair a painful joint Stem cell transplant.

Approval is specific, too. On December 18, 2024, the U.S. FDA approved Ryoncil, a donor bone-marrow-derived mesenchymal stromal cell therapy, for steroid-refractory acute graft-versus-host disease in children aged 2 months and older. That means a particular complication after a donor blood stem cell transplant that has not responded to steroid treatment, not a general approval for joint pain or anti-aging Fda approves remestemcel l rknd steroid refractory acute graft versus host disease pediatric.

If a clinical trial is proposed, ask for its registration number, eligibility criteria, consent documents, and oversight details. Registration alone does not establish effectiveness; FDA also warns that a ClinicalTrials.gov listing does not mean a product is legally marketed in the United States Important patient and consumer information about regenerative medicine therapies.

For a service offered under Japan’s Act on the Safety of Regenerative Medicine, ask for the provision-plan number and the documents describing your proposed treatment. MHLW sets out a framework for provision procedures, distinct from product approval; filing a plan is not proof that the treatment works Index. Check how registration and approval differ in Japan when interpreting the paperwork, rather than treating a registration number as a quality rating.

Discusses Evidence, Risks, and Alternatives

Ask what human evidence supports this exact product and route for your condition. The doctor should explain who was studied, how many people took part, whether there was a comparison group, what improved, how long follow-up lasted, and what adverse events occurred. An improvement in a laboratory measure is not automatically an improvement in pain, mobility, or daily life.

Risk discussion should match the proposed procedure. FDA has received reports of blindness, tumor formation, and infections associated with unapproved regenerative products, and lists concerns including unwanted immune reactions, collection or administration-site reactions, and contamination. These warnings cover different products and procedures; they are not a single complication rate for every cell treatment Important patient and consumer information about regenerative medicine therapies.

Transplant counseling has its own risks. Cancer conditioning treatment and transplantation can involve infection, bleeding, infertility, and organ damage; donor transplantation can also cause graft-versus-host disease, in which donor immune cells attack the recipient’s tissues. These risks should not be presented as the risk profile of a clinic injection Stem cell transplant.

Ask what established care remains available and what could happen if you delay it. Depending on the diagnosis, the alternatives to discuss may include rehabilitation, medicines, surgery, monitoring, or no intervention now. Get clear instructions about which symptoms after any proposed procedure require urgent attention, who handles complications, and what follow-up you would need at home.

Sets Out Costs and Next Steps

Request an itemized quote that separates the consultation fee from any tests, cell collection, processing, storage, administration, and follow-up. Ask whether the price is per session or for a course, what happens if treatment is cancelled after assessment, and which complication-related costs are excluded. Compare the same stem cell treatment cost components in Japan rather than headline prices.

If treatment is proposed, request written information about its status, expected benefits and uncertainties, risks, alternatives, and follow-up before deciding. Ask how long the quote remains valid. You can request time to review the documents and seek another medical opinion rather than deciding under payment pressure.

Questions to Ask Before You Leave

  • What diagnosis explains my symptoms, and what remains uncertain?
  • What makes me suitable or unsuitable for this exact intervention?
  • What human evidence applies to someone with my condition and treatment history?
  • Is this an approved product for this use, a clinical trial, or a clinic service under a provision plan?
  • What benefit would we measure, by when, and what would count as no benefit?
  • What checks, costs, and follow-up responsibilities remain before I decide?

A Practical Example

Suppose you are discussing knee pain and bring an MRI report but not the original images. Ask whether the doctor can answer the clinical question from the report or needs the images before advising you. If the recommendation is provisional, note exactly what could change it.

Put your own experience into a short note: when symptoms started, which activities are difficult, what treatment you tried, and what changed afterward. Use your actual walking time or activity limit if you know it; do not guess a number to make the account sound precise. Bring that note back to the agreed treatment goal before the appointment ends.

What Happens Afterward

Ask for an assessment summary, even if no treatment is recommended. It should distinguish what the doctor has decided from what still needs checking. If more information is required, confirm how to send it, who reviews it, and how you receive the answer. A written proposal does not itself mean you have consented to treatment.

If you are considering traveling, confirm which decisions can be made remotely and which require attendance. Ask separately about the timing of assessment, any treatment, and follow-up. Do not assume they happen on the same day.

A useful consultation leaves you knowing why the treatment is or is not appropriate, what remains uncertain, and what your next step is. It does not need to end with a booking.

Pause if you are promised guaranteed regrowth, discouraged from standard care or a second opinion, or asked to pay before anyone can identify the proposed product and explain its evidence and risks.

Planning a consultation in Japan? Ask which records are needed, how to send them securely, and what the appointment includes before arranging travel.

Contact the patient support team

Sources